PHARMPROTECH HOLDING ApS — Credit Rating and Financial Key Figures
CVR number: 29174644
Godtfreds Høje 6, Gevninge 4000 Roskilde
toch@scantago.com
tel: 40954285
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -6.00 | -10.00 | -10.00 | -17.10 | - 163.69 |
| Total depreciation | - 104.61 | - 104.61 | |||
| EBIT | -6.00 | - 114.61 | 94.61 | -17.10 | - 163.69 |
| Other financial income | 49.86 | 272.88 | 343.47 | 462.37 | 1 001.60 |
| Other financial expenses | -88.50 | - 200.77 | - 103.27 | - 120.07 | - 348.92 |
| Reduction non-current investment assets | - 100.00 | 100.00 | |||
| Net income from associates (fin.) | 5 478.37 | 1 411.27 | 5 216.79 | 4 940.18 | 5 500.78 |
| Pre-tax profit | 5 433.73 | 1 268.77 | 5 651.61 | 5 265.38 | 5 989.77 |
| Income taxes | 6.35 | 9.38 | -70.62 | -75.79 | - 111.85 |
| Net earnings | 5 440.08 | 1 278.15 | 5 580.99 | 5 189.59 | 5 877.92 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 16 821.05 | 13 516.98 | 17 390.84 | 21 035.60 | 22 078.48 |
| Investments total | 16 821.05 | 13 516.98 | 17 390.84 | 21 035.60 | 22 078.48 |
| Non-current loans receivable | 100.00 | ||||
| Long term receivables total | 100.00 | ||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 8 719.32 | 6 699.37 | 7 042.77 | 11 898.57 | 16 194.00 |
| Current other receivables | 129.61 | 761.59 | |||
| Current deferred tax assets | 1 640.13 | 2 477.43 | 2 903.72 | 1 693.22 | 1 488.61 |
| Short term receivables total | 10 489.05 | 9 176.79 | 9 946.49 | 13 591.79 | 18 444.19 |
| Cash and bank deposits | 13.25 | 8.76 | 294.61 | 52.77 | 8.24 |
| Cash and cash equivalents | 13.25 | 8.76 | 294.61 | 52.77 | 8.24 |
| Balance sheet total (assets) | 27 423.35 | 22 702.53 | 27 631.95 | 34 680.16 | 40 530.92 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 56.50 | 57.20 | 58.90 | 61.00 | |
| Other reserves | 13 911.46 | 7 583.90 | 11 550.70 | 15 090.87 | 16 430.07 |
| Retained earnings | -2 689.06 | 9 021.38 | 6 332.74 | 8 314.65 | 12 104.05 |
| Profit of the financial year | 5 440.08 | 1 278.15 | 5 580.99 | 5 189.59 | 5 877.92 |
| Shareholders equity total | 16 843.99 | 18 065.64 | 23 589.43 | 28 779.02 | 34 598.04 |
| Non-current deferred tax liabilities | 1 106.69 | 634.11 | 1 709.03 | 1 401.93 | 1 270.54 |
| Non-current liabilities total | 1 106.69 | 634.11 | 1 709.03 | 1 401.93 | 1 270.54 |
| Current trade creditors | 24.00 | 6.00 | 6.00 | 6.00 | 6.00 |
| Current owed to group member | 8 825.54 | 3 641.36 | 1 521.23 | 4 322.55 | 4 622.00 |
| Short-term deferred tax liabilities | 511.83 | 355.34 | 806.26 | 167.08 | 34.34 |
| Other non-interest bearing current liabilities | 111.31 | 0.09 | 3.59 | ||
| Current liabilities total | 9 472.68 | 4 002.79 | 2 333.48 | 4 499.21 | 4 662.34 |
| Balance sheet total (liabilities) | 27 423.35 | 22 702.53 | 27 631.95 | 34 680.16 | 40 530.92 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.